Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1954 3
1988 2
1989 1
1990 2
1991 2
1992 1
1993 1
1994 3
1995 2
1996 1
1997 4
1998 1
1999 3
2000 1
2001 4
2002 4
2003 5
2004 10
2005 9
2006 14
2007 18
2008 20
2009 21
2010 20
2011 26
2012 26
2013 27
2014 46
2015 35
2016 38
2017 48
2018 49
2019 36
2020 31
2021 45
2022 34
Text availability
Article attribute
Article type
Publication date

Search Results

535 results
Results by year
Filters applied: . Clear all
Page 1
The cuprizone model for demyelination.
Torkildsen O, Brunborg LA, Myhr KM, Bø L. Torkildsen O, et al. Among authors: bo l. Acta Neurol Scand Suppl. 2008;188:72-6. doi: 10.1111/j.1600-0404.2008.01036.x. Acta Neurol Scand Suppl. 2008. PMID: 18439226 Review.
Protective properties of heme oxygenase-1 expressed in umbilical cord mesenchymal stem cells help restore the ovarian function of premature ovarian failure mice through activating the JNK/Bcl-2 signal pathway-regulated autophagy and upregulating the circulating of CD8+CD28- T cells.
Yin N, Wu C, Qiu J, Zhang Y, Bo L, Xu Y, Shi M, Zhu S, Yang G, Mao C. Yin N, et al. Among authors: bo l. Stem Cell Res Ther. 2020 Feb 4;11(1):49. doi: 10.1186/s13287-019-1537-x. Stem Cell Res Ther. 2020. PMID: 32019599 Free PMC article. Clinical Trial.
Drug resistance: from bacteria to cancer.
Patel H, Wu ZX, Chen Y, Bo L, Chen ZS. Patel H, et al. Among authors: bo l. Mol Biomed. 2021 Sep 10;2(1):27. doi: 10.1186/s43556-021-00041-4. Mol Biomed. 2021. PMID: 35006446 Free PMC article. Review.
Disease-modifying therapy for multiple sclerosis.
Holmøy T, Nygaard GO, Myhr KM, Bø L. Holmøy T, et al. Among authors: bo l. Tidsskr Nor Laegeforen. 2021 May 10;141(8). doi: 10.4045/tidsskr.21.0155. Print 2021 May 25. Tidsskr Nor Laegeforen. 2021. PMID: 34047171 Free article. English, Norwegian.
[Correction: Disease-modifying therapy for multiple sclerosis].
Holmøy T, Nygaard GO, Myhr KM, Bø L. Holmøy T, et al. Among authors: bo l. Tidsskr Nor Laegeforen. 2021 Jun 10;141(10). doi: 10.4045/tidsskr.21.0454. Print 2021 Jun 29. Tidsskr Nor Laegeforen. 2021. PMID: 34182741 Free article. Norwegian. No abstract available.
Visual dysfunction in multiple sclerosis.
Hoff JM, Dhayalan M, Midelfart A, Tharaldsen AR, Bø L. Hoff JM, et al. Among authors: bo l. Tidsskr Nor Laegeforen. 2019 Aug 2;139(11). doi: 10.4045/tidsskr.18.0786. Print 2019 Aug 20. Tidsskr Nor Laegeforen. 2019. PMID: 31429247 Free article. Review. English, Norwegian.
Melatonin and hypothalamic-pituitary-gonadal axis.
Shi L, Li N, Bo L, Xu Z. Shi L, et al. Among authors: bo l. Curr Med Chem. 2013;20(15):2017-31. doi: 10.2174/09298673113209990114. Curr Med Chem. 2013. PMID: 23410151 Review.
Emerging Pollutants - Part II: Treatment.
Bo L, Shengen Z, Chang CC. Bo L, et al. Water Environ Res. 2017 Oct 1;89(10):1829-1865. doi: 10.2175/106143017X15023776270674. Water Environ Res. 2017. PMID: 28954684 Review.
Emerging Pollutants - Part II: Treatment.
Bo L, Shengen Z, Chang CC. Bo L, et al. Water Environ Res. 2016 Oct;88(10):1876-904. doi: 10.2175/106143016X14696400495857. Water Environ Res. 2016. PMID: 27620112 Review.
535 results